VRS
CUE icon

Virginia Retirement Systems’s Cue Biopharma CUE Stock Holding History

Virginia Retirement Systems’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$54K Sell
367
-166
-31% -$35.2K ﹤0.01% 1102
2021
Q4 		$181 Buy
533
+120
+29% +$46.4K ﹤0.01% 1067
2021
Q3 		$181K Buy
413
+53
+15% +$18.5K ﹤0.01% 954
2021
Q2 		$126K Buy
+360
New +$140K ﹤0.01% 999

Other funds holding CUE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virginia Retirement Systems's CUE Position: Q1 2022 in Review

Virginia Retirement Systems reduced its Cue Biopharma (CUE) stake by 31% in Q1 2022, selling an estimated $35.2K and leaving 367 shares worth $54K. The position accounts for ﹤0.01% of the portfolio, ranked #1102.

Virginia Retirement Systems first reported a position in CUE in Q2 2021 and has held it in 4 quarters since. The position peaked at $181K in Q3 2021. 100 funds tracked by Wall St. Rank hold CUE as of Q1 2022.

  • Virginia Retirement Systems held 367 shares of Cue Biopharma worth $54K as of Q1 2022.
  • Virginia Retirement Systems sold 166 Cue Biopharma shares in Q1 2022, an estimated $35.2K.
  • Cue Biopharma made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q1 2022, its #1102 holding.
  • Virginia Retirement Systems first reported a position in Cue Biopharma in Q2 2021 and has held it in 4 quarters since.
  • Virginia Retirement Systems's Cue Biopharma position peaked at $181K in Q3 2021.
  • 100 funds tracked by Wall St. Rank held Cue Biopharma as of Q1 2022.

Based on Virginia Retirement Systems's 13F filing for Q1 2022, filed 21 Apr 2022.